hydralazine has been researched along with Infarct in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hammond, TG | 1 |
| Mosesson, MW | 1 |
| Omae, T | 1 |
| Tanaka, K | 1 |
2 other studies available for hydralazine and Infarct
| Article | Year |
|---|---|
Fatal small-bowel necrosis and pulmonary hypertension in sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Humans; Hydralazine; Hypertension, Pulmonary; Hypotension; Infarction; I | 1989 |
Release of pressor substances from infarcted kidneys in rats. I. Effect of chronic administration of hydralazine.
Topics: Administration, Oral; Animals; Blood Pressure; Female; Hydralazine; Infarction; Kidney; Kidney Trans | 1971 |